Infectious diseases, imposing density-dependent mortality on MHC/HLA variation, can account for balancing selection and MHC/HLA polymorphism
Journal:
arXiv
Published Date:
Jan 1, 2025
Abstract
The human MHC transplantation loci (HLA-A, -B, -C, -DPB1, -DQB1, -DRB1) are
the most polymorphic in the human genome. It is generally accepted this
polymorphism reflects a role in presenting pathogen-derived peptide to the
adaptive immune system. Proposed mechanisms for the polymorphism such as
negative frequency-dependent selection (NFDS) and heterozygote advantage (HA)
focus on HLA alleles, not haplotypes. Here, we propose a model for the
polymorphism in which infectious diseases impose independent density-dependent
regulation on HLA haplotypes. More specifically, a complex pathogen environment
drives extensive host polymorphism through a guild of HLA haplotypes that are
specialised and show incomplete peptide recognition. Separation of haplotype
guilds is maintained by limiting similarity. The outcome is a wide and stable
range of haplotype densities at steady-state in which effective Fisher
fitnesses are zero. Densities, and therefore frequencies, emerge theoretically
as alternative measures of fitness. A catalogue of ranked frequencies is
therefore one of ranked fitnesses. The model is supported by data from a range
of sources including a Caucasian HLA dataset compiled by the US National Marrow
Donor Program (NMDP). These provide evidence of positive selection on the top
350-2000 5-locus HLA haplotypes taken from an overall NMDP sample set of 10E5.
High-fitness haplotypes drive the selection of 137 high-frequency alleles
spread across the 5 HLA loci under consideration. These alleles demonstrate
positive epistasis and pleiotropy in the formation of haplotypes. Allelic
pleiotropy creates a network of highly inter-related HLA haplotypes that
account for 97% of the census sample. We suggest this network has properties of
a quasi-species and is itself under selection. We also suggest this is the
origin of balancing selection in the HLA system.